• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Sidus Space Appoints Bill White as Chief Financial Officer

    2/8/24 8:30:00 AM ET
    $PRPH
    $SIDU
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Telecommunications Equipment
    Telecommunications
    Get the next $PRPH alert in real time by email

    Sidus Space (NASDAQ:SIDU) (the "Company" or "Sidus"), a multi-faceted Space and Data-as-a-Service company, today announced the appointment of Bill White as Chief Financial Officer, effective February 20, 2024.

    Mr. White will oversee the Company's accounting, financial planning, capital raise, treasury, legal and regulatory functions. Mr. White has more than 30 years of experience in financial management, operations, and business development. He most recently served as Chief Financial Officer of ProPhase Labs, Inc. (NASDAQ:PRPH) and prior to ProPhase he was CFO, treasurer, and secretary of Intellicheck, Inc., a technology company listed on the NasdaqGM. Mr. White has broad domestic and international experience including managing rapid and significant growth, import/export, implementing tough cost management initiatives, exploiting new growth opportunities, mergers and acquisitions, strategic planning, resource allocation, tax compliance and organization development.

    "Bill's deep experience as a public company executive alongside his remarkable proficiency in capital markets and M&A, aligns perfectly with the current stage of Sidus' growth," said Carol Craig, Chief Executive Officer of Sidus.

    "I am honored to serve Sidus at this critical time in its growth and evolution and am excited to work with Carol and the management team to capitalize upon the growth opportunities ahead and deliver long-term value for shareholders," said Bill White, incoming Chief Financial Officer.

    Teresa Burchfield has confirmed her intention to step down as Chief Financial Officer after two years with the Company. Burchfield will remain with the Company, serving in an advisory role, to assist White with the transition.

    Craig added, "I have enjoyed working with Teresa and, during her tenure as chief financial officer at the Company, she has made innumerable and invaluable contributions to its success and growth. On behalf of the Board and the entire Sidus team, I'd like to thank Teresa for her valuable contributions and for laying the groundwork for our continued growth in the public and space sectors."

    About Sidus Space

    Sidus Space (NASDAQ:SIDU) is a Space and Data-as-a-Service satellite company focused on mission-critical hardware manufacturing; multi-disciplinary engineering services; satellite design, production, launch planning, mission operations; and in-orbit support. The Company is located in Cape Canaveral, Florida, where it operates from a 35,000-square-foot manufacturing, assembly, integration, and testing facility focused on vertically integrated Space-as-a-Service solutions including end-to-end satellite support.

    Sidus Space has a mission of Bringing Space Down to Earth™ and a vision of enabling space flight heritage status for new technologies while delivering data and predictive analytics to domestic and global customers. Any corporation, industry, or vertical can start their journey off-planet with Sidus Space's rapidly scalable, low-cost satellite services, space-based solutions, and testing alternatives. More than just a "Satellite-as-a-Service" provider, Sidus Space is a trusted Mission Partner–from concept to Low Earth Orbit and beyond. Sidus Space is ISO 9001:2015, AS9100 Rev. D certified, and ITAR registered.

    Forward-Looking Statements

    Statements in this press release about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, may constitute ‘forward-looking statements' within the meaning of The Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements relating to the expected trading commencement and closing dates. The words ‘anticipate,' ‘believe,' ‘continue,' ‘could,' ‘estimate,' ‘expect,' ‘intend,' ‘may,' ‘plan,' ‘potential,' ‘predict,' ‘project,' ‘should,' ‘target,' ‘will,' ‘would' and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including: the uncertainties related to market conditions and other factors described more fully in the section entitled ‘Risk Factors' in Sidus Space's Annual Report on Form 10-K for the year ended December 31, 2022, and other periodic reports filed with the Securities and Exchange Commission. Any forward-looking statements contained in this press release speak only as of the date hereof, and Sidus Space, Inc. specifically disclaims any obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20240208062368/en/

    Get the next $PRPH alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $PRPH
    $SIDU

    CompanyDatePrice TargetRatingAnalyst
    ProPhase Labs Inc.
    $PRPH
    1/14/2022$12.00 → $15.00Buy
    HC Wainwright & Co.
    ProPhase Labs Inc.
    $PRPH
    12/20/2021$12.00Buy
    HC Wainwright & Co.
    ProPhase Labs Inc.
    $PRPH
    10/13/2021Buy → Neutral
    Dawson James
    More analyst ratings

    $PRPH
    $SIDU
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • ProPhase Labs Announces Formation of Clinical Science Advisory Board to Accelerate Commercialization of BE-SmartTM Esophageal Disease Diagnostic Platform

      UNIONDALE, NY, June 06, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ:PRPH), (the "Company" or "ProPhase") a next generation biotech, genomics and consumer products company, today announced the formation of its Clinical Science Advisory Board to support the clinical adoption and commercialization of its breakthrough BE-SmartTM molecular test for esophageal disease. The advisory board will provide expert strategic guidance as ProPhase leads the regulatory and commercialization pathway for BE-Smart, with the goal of establishing a new clinical and economic standard in the early detection and management of esophageal cancer risk. A full data package detailing the test's validation and c

      6/6/25 7:00:00 AM ET
      $PRPH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Sidus Space Launches Fortis™ VPX: A Ruggedized, AI-Powered 3U OpenVPX Module Supporting Complex Missions from Sea to Space

      Modular computing system unlocks new market opportunities across space, defense, and maritime sectors Sidus Space (NASDAQ:SIDU), (the "Company" or "Sidus"), an innovative space and defense technology provider, today announced the launch of Fortis™ VPX, a ruggedized, modular, SOSA™ aligned computing system engineered for high-reliability command and data handling (C&DH), advanced artificial intelligence/machine learning (AI/ML) processing, and precision navigation in extreme environments. The Fortis™ line of products establishes a new cornerstone in Sidus' expanding portfolio of space-qualified and defense-grade technologies, designed to support the increasing demand for edge computing acro

      5/22/25 8:30:00 AM ET
      $SIDU
      Telecommunications Equipment
      Telecommunications
    • ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2025

      Highlights Multiple Significant Potential Liquidity Events Anticipated Within the Next Few Months Completes Significant Reductions in Overhead and Expenses BE-Smart Esophageal Cancer Test Study has been Submitted in the Journal of Clinical Gastrointestinal Hepatology Company to hold a virtual conference call Tuesday, May 20, 2025, at 10:00 AM ET GARDEN CITY, NY, May 20, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ:PRPH), (the "Company" or "ProPhase") a next generation biotech, genomics and consumer products company, today reported its financial and operational results for Q1 ended March 31, 2025, and outlined significant strategic corporate developments. Ted Karkus, CEO of ProP

      5/20/25 8:00:00 AM ET
      $PRPH
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $PRPH
    $SIDU
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • HC Wainwright & Co. reiterated coverage on ProPhase Labs with a new price target

      HC Wainwright & Co. reiterated coverage of ProPhase Labs with a rating of Buy and set a new price target of $15.00 from $12.00 previously

      1/14/22 6:36:15 AM ET
      $PRPH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • HC Wainwright & Co. initiated coverage on ProPhase Labs with a new price target

      HC Wainwright & Co. initiated coverage of ProPhase Labs with a rating of Buy and set a new price target of $12.00

      12/20/21 6:25:15 AM ET
      $PRPH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • ProPhase downgraded by Dawson James

      Dawson James downgraded ProPhase from Buy to Neutral

      10/13/21 10:48:44 AM ET
      $PRPH
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $PRPH
    $SIDU
    SEC Filings

    See more
    • SEC Form 10-Q filed by ProPhase Labs Inc.

      10-Q - ProPhase Labs, Inc. (0000868278) (Filer)

      5/20/25 4:06:42 PM ET
      $PRPH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • ProPhase Labs Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - ProPhase Labs, Inc. (0000868278) (Filer)

      5/20/25 8:00:55 AM ET
      $PRPH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form NT 10-Q filed by ProPhase Labs Inc.

      NT 10-Q - ProPhase Labs, Inc. (0000868278) (Filer)

      5/16/25 5:00:09 PM ET
      $PRPH
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $PRPH
    $SIDU
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Shuman Jeffrey S bought $24,689 worth of shares (15,000 units at $1.65) (SEC Form 4)

      4 - Sidus Space Inc. (0001879726) (Issuer)

      6/13/25 4:15:18 PM ET
      $SIDU
      Telecommunications Equipment
      Telecommunications

    $PRPH
    $SIDU
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Shuman Jeffrey S bought $24,689 worth of shares (15,000 units at $1.65) (SEC Form 4)

      4 - Sidus Space Inc. (0001879726) (Issuer)

      6/13/25 4:15:18 PM ET
      $SIDU
      Telecommunications Equipment
      Telecommunications
    • SEC Form 4 filed by Chief Financial Officer Parekh Adarsh

      4 - Sidus Space Inc. (0001879726) (Issuer)

      5/2/25 6:05:10 AM ET
      $SIDU
      Telecommunications Equipment
      Telecommunications
    • SEC Form 4 filed by Chief Financial Officer Parekh Adarsh

      4 - Sidus Space Inc. (0001879726) (Issuer)

      2/26/25 4:45:09 PM ET
      $SIDU
      Telecommunications Equipment
      Telecommunications

    $PRPH
    $SIDU
    Leadership Updates

    Live Leadership Updates

    See more
    • ProPhase Labs hires Stuart Hollenshead as COO, the former COO and CBO of Barstool Sports

      GARDEN CITY, NY, Feb. 18, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ:PRPH) ("ProPhase" or the "Company"), a next-generation biotech, genomics, and consumer products company, today announced the appointment of Stu Hollenshead as Chief Operating Officer, marking a pivotal step in the company's expansion into consumer-centered health and wellness products. As COO, Hollenshead will focus on accelerating ProPhase Labs' consumer-facing strategy, leveraging his deep expertise in direct-to-consumer growth, subscription models, digital marketing, and audience monetization to position the company as a leader in science-backed health solutions. The Company plans to provide additional updat

      2/18/25 8:00:00 AM ET
      $PRPH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Sidus Space Appoints Adarsh Parekh as New Chief Financial Officer (CFO) to Spearhead Strategic Financial Initiatives

      Sidus Space (NASDAQ:SIDU), an innovative and agile space mission enabler, today announced the appointment of Adarsh Parekh as its new Chief Financial Officer, effective January 27, 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250121637159/en/(Photo: Business Wire) Exceptional Financial Leadership Mr. Parekh brings over two decades of financial expertise marked by: $3 billion in M&A, capital markets and direct investing experience A proven record of scaling organizations in industries including aerospace, medical technology, and agriculture A history of implementing strategies to drive profitability and sustain

      1/21/25 8:30:00 AM ET
      $SIDU
      Telecommunications Equipment
      Telecommunications
    • Sidus Space Appoints Former Airbus US Space & Defense Executive Director, Lavanson (LC) Coffey III, to its Board of Directors

      Sidus Space (NASDAQ:SIDU) (the "Company" or "Sidus"), a provider of end-to-end precision Space Infrastructure solutions that include satellite Data-as-a-Service on its proprietary on-orbit platform, today announced that its Board of Directors has appointed Lavanson (LC) Coffey as an Independent Director, effective August 27, 2024. Carol Craig, Chairman and CEO of Sidus Space, stated, "We are thrilled to welcome Mr. Coffey to the Sidus Board. With 40 years of aerospace experience and senior leadership across military, government, and commercial sectors, he brings invaluable insights and strategic direction that will help us build upon our recent commercial space successes." LC Coffey add

      9/3/24 8:30:00 AM ET
      $SIDU
      Telecommunications Equipment
      Telecommunications

    $PRPH
    $SIDU
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Sidus Space Inc.

      SC 13G/A - Sidus Space Inc. (0001879726) (Subject)

      11/14/24 7:31:47 PM ET
      $SIDU
      Telecommunications Equipment
      Telecommunications
    • Amendment: SEC Form SC 13G/A filed by Sidus Space Inc.

      SC 13G/A - Sidus Space Inc. (0001879726) (Subject)

      6/28/24 4:13:44 PM ET
      $SIDU
      Telecommunications Equipment
      Telecommunications
    • SEC Form SC 13D/A filed by ProPhase Labs Inc. (Amendment)

      SC 13D/A - ProPhase Labs, Inc. (0000868278) (Subject)

      3/19/24 4:18:00 PM ET
      $PRPH
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $PRPH
    $SIDU
    Financials

    Live finance-specific insights

    See more
    • ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2025

      Highlights Multiple Significant Potential Liquidity Events Anticipated Within the Next Few Months Completes Significant Reductions in Overhead and Expenses BE-Smart Esophageal Cancer Test Study has been Submitted in the Journal of Clinical Gastrointestinal Hepatology Company to hold a virtual conference call Tuesday, May 20, 2025, at 10:00 AM ET GARDEN CITY, NY, May 20, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ:PRPH), (the "Company" or "ProPhase") a next generation biotech, genomics and consumer products company, today reported its financial and operational results for Q1 ended March 31, 2025, and outlined significant strategic corporate developments. Ted Karkus, CEO of ProP

      5/20/25 8:00:00 AM ET
      $PRPH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Sidus Space Reports First Quarter 2025 Financial Results and Provides Business Update

      Sidus Space (NASDAQ:SIDU) (the "Company" or "Sidus"), an innovative, agile space mission enabler, today announced its financial results for the first quarter ended March 31, 2025, and provided a business update. The Company is scheduled to host a conference call and webcast today, Thursday, May 15, at 5:00 p.m. ET. "Q1 was a pivotal quarter for Sidus as we launched LizzieSat®-3 (LS-3) and advanced a major technology rollout, laying the foundation for future revenue growth. We remain committed to delivering integrated, AI-driven solutions across space, air, land, and sea and are confident in our long-term trajectory," said Carol Craig, Sidus Chairwoman and CEO. "With growing commercial and

      5/15/25 4:45:00 PM ET
      $SIDU
      Telecommunications Equipment
      Telecommunications
    • ProPhase Labs Inc. to Present First Quarter 2025 Financial Results on May 20, 2025

      GARDEN CITY, NY, May 13, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ:PRPH), (the "Company" or "ProPhase") a next generation biotech, genomics and consumer products company, announced today that they will be presenting first quarter 2025 financial results on a virtual conference call hosted by Renmark Financial on May 20, 2025, at 10:00 am EDT. Ted Karkus, CEO, looks forward to providing shareholders with an update on several positive activities, including the initiative to sell the Company's wholly owned subsidiary, Nebula Genomics, and the Crown Medical Collections initiative to collect tens of millions of dollars in accounts receivable. A press release detailing these results wi

      5/13/25 8:00:00 AM ET
      $PRPH
      Biotechnology: Pharmaceutical Preparations
      Health Care